Opinion · 19 Dec 2025
Conference abstractPublished 16 Jun 2016
Alkaptonuria and Ochronosis
National Institute of Rheumatic Disease, Slovakia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Alkaptonuria is a rare inherited genetic disorder of phenylalanine and tyrosine metabolism. This is an autosomal recessive condition that is due to a defect in the enzyme homogentisate 1, 2-dioxygenase, which participates in the degradation of tyrosine. As a result, homogentisic acid and its oxide accumulate in the blood and are excreted in urine in large amounts. The polymer of homogentisc acid called alkapton impregnates bradotrophic tissues. The first signs of deposition of the ochronotic pigment can be detected accidentally during professional examination of the anterior segment of the eye. The ochronotic pigmentation of the ocular structures is present in approximately 70% of patients. In addition to the sclera, lumps of the ochronotic pigment can be found in the conjunctiva and cornea. Since similar pigmentation of the cornea is not present in other medical conditions, this finding is regarded as pathognomic for alkaptonuricochronosis. The diagnosis of alkaptonuria is based on the characteristic findings in urine. Alkaptonuria patients do not seek medical help due to difficulties with visionâÂ?Â? they are without subjective complications. In parallel with the ocular manifestations, ochronotic changes can be found in the hearing organ. Color changes of the auricle are visible in the 10th to 15th year of life. Also typical for alkaptonuricochronosis are changes in the skin, mainly brownish or bluish pigmentation of the skin under the arm, in the face, neck and hands, and rarely on the nails. Given their visibility they may be relevant for the early diagnosis alkaptonuricochronosis. Ochronotic pigment is deposited also on the internal organs. In the field of cardiovascular organs it is the myocardium and blood vessels. From a clinical point of view, the most serious process takes place in the joints and is called ochronoticarthropathy. Therapy of alkaptonuria with Nitisinone is underway.
Subjects
RheumatologyOrthopaedicsAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Rheumatology: Current Research.
Opinion · 19 Dec 2025
Specialized Care for Complex Rheumatic Disorders
Perspective · 19 Dec 2025
Rheumatology and Musculoskeletal Health
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalRheumatology: Current Research
- SubjectRheumatology
- SubjectOrthopaedics
- BylineArticles whose byline prints “Jozef Rovensky”

